Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Shen: Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma.... (0.13 sec) 

Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With …

- diabetesjournals.org
J Shen, DK Arnett, LD Parnell, JM Peacock, CQ Lai, … - Diabetes Care, 2008 - Am Diabetes Assoc
RESULTS—There were strong associations of m301G>A>T (rs3091244; P = 0.003), i178T>A
(rs1417938; P = 0.001), 3u1273C>T (rs1130864; P = 0.001), and 3u2131C>T (rs1205; P <
0.001) with baseline CRP levels. Moreover, among subjects with the metabolic syndrome, ...
Cited by 11 - Related articles - BL Direct - All 13 versions

C-reactive protein gene polymorphism 1009A> G is associated with serum CRP …


WHH Sheu, YDI Chen, CY Yu, X Guo, TC Lee, WJ Lee, … - Clinica Chimica Acta, 2007 - Elsevier
Increased concentrations of high-sensitivity CRP (hs-CRP) are associated with increased risk
of cardiovascular disease. This increase might be caused by low-grade inflammation, but a number
of studies have suggested that serum CRP concentrations are under genetic control. ...
Cited by 4 - Related articles - All 4 versions

The-256T> C polymorphism in the apolipoprotein A-II gene promoter is associated …


D Corella, DK Arnett, MY Tsai, EK Kabagambe, … - Clinical …, 2007 - Am Assoc Clin Chem
(Clinical Chemistry. 2007;53:1144-1152.) © 2007 American Association for Clinical
Chemistry, Inc. ... 1 Nutrition and Genomics Laboratory, Jean Mayer-US Department of Agriculture
Human Nutrition Research Center on Aging, Tufts University, Boston, MA. 2 Genetic and ...
Cited by 23 - Related articles - BL Direct - All 16 versions

[PDF] Extralipid effects of micronized fenofibrate in dyslipidemic patients


B Okopieñ, M Haberka, A Madej, D Belowski, K … - Pharmacological …, 2006 - if-pan.krakow.pl
Abstract: The aim of this study was to evaluate the levels of lipid and extralipid parameters in
patients with atherogenic dyslipidemia. We investigated the lipid-lowering therapeutic efficacy
of fenofibrate and its extralipid influence on oxidized low-density lipoprotein (oxLDL), C- ...
Cited by 6 - Related articles - View as HTML - BL Direct - All 10 versions

Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density …


JC Hogue, B Lamarche, AJ Tremblay, J Bergeron, C … - Metabolism, 2008 - Elsevier
Type 2 diabetes mellitus is associated with elevated plasma triglyceride levels, low high-density
lipoprotein cholesterol, and a high incidence of cardiovascular disease.
Hydroxymethylglutaryl–coenzyme A reductase inhibitors and fibrates are frequently used ...
Cited by 6 - Related articles - All 12 versions

Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study

- nih.gov
A Cherubini, C Andres-Lacueva, A Martin, F … - … of Gerontology Series …, 2007 - Geron Soc America
1 Institute of Gerontology and Geriatrics, Department of Clinical and Experimental Medicine,
Perugia University, Italy. 2 Department of Nutrition and Food Science–Xarxa de Referència en
Tecnologia d'Aliments de la Generalitat de Catalunya, Barcelona University, Spain. 3 ...
Cited by 7 - Related articles - BL Direct - All 3 versions

The metabolic syndrome, inflammation and cardiovascular disease in type 2 …


AW Roberts, M Evans - Current Opinion in Lipidology, 2004 - journals.lww.com
The prevalence of type 2 diabetes continues to rise worldwide and is projected to increase from
the current figure of 150 million, to 220 million by the year 2010. This rapid increase is closely
linked to an epidemic of obesity, which is an integral part of the so-called metabolic ...
Cited by 7 - Related articles - BL Direct - All 3 versions

DNA variants, plasma levels and variability of C-reactive protein in myocardial …

- oxfordjournals.org
M Kolz, W Koenig, M Muller, M Andreani, S … - European Heart …, 2008 - Eur Soc Cardiology
Methods and results: One thousand and three myocardial infarction (MI) survivors were recruited
in six European cities, and C-reactive protein concentrations were measured repeatedly during
a 6-month period. We investigated 114 polymorphisms in 13 genes, all involved in the ...
Cited by 8 - Related articles - BL Direct - All 4 versions

Fenofibrate reduces fasting and postprandial inflammatory responses among …


RS Rosenson, AL Huskin, DA Wolff, IB Helenowski, AW … - Atherosclerosis, 2008 - Elsevier
Fenofibrate treatment reduced concentrations of monohydroxy fatty acids (OH-FA) by 15.5%
(p = 0.001), lipopolysaccharide activated monocyte chemotactic protein-1 (MCP-1/CCL2) production
in fasting blood samples by 3.4% (p = 0.01 vs. placebo), macrophage inflammatory ...
Cited by 9 - Related articles - All 22 versions

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a …


K Tziomalos, VG Athyros - International Journal of Nanomedicine, 2006 - pubmedcentral.nih.gov
Cardiovascular disease is the major cause of mortality worldwide and accounts for approximately
40% of all deaths. Dyslipidemia is one of the primary causes of atherosclerosis and effective
interventions to correct dyslipidemia should form an integral component of any strategy ...
Cited by 10 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google